Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

The MAGELLAN Study: An Analysis of Outcomes Utilizing D-Dimer

Alexander T Cohen, Theodore E Spiro, Paul Burton, Harry R Büller, Lloyd Haskell, Da-Yi Hu, Russell D Hull, Alexandre Mebazaa, Geno J Merli, Sebastian Schellong, Alex C Spyropoulos, Victor F Tapson

Blood (2011) 118 (21): 542.

https://doi.org/10.1182/blood.V118.21.542.542

Published: 2011

Journal Articles

Venous Thromboembolism Risk in Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Sub-Analysis of the EXCLAIM Study

Alexander GG Turpie, MD, Russell D Hull, MBBS, Sebastian M Schellong, MD, Victor F Tapson, MD, Manuel Monreal, MD, Meyer Michel Samama, MD, PharmD, Roger D Yusen, MD, MPH

Blood (2008) 112 (11): 433.

https://doi.org/10.1182/blood.V112.11.433.433

Published: 2008

Journal Articles

The Impact of Age on the Efficacy and Safety of Extended-Duration Thromboprophylaxis in Acutely Ill Medical Patients with Recent Immobility: A Sub-Group Analysis from the EXCLAIM Study

Roger D Yusen, Russell D Hull, Sebastian M Schellong, Victor F Tapson, Manuel Monreal, Michel Meyer Samama, Min Chen, Alexander GG Turpie

Blood (2008) 112 (11): 438.

https://doi.org/10.1182/blood.V112.11.438.438

Published: 2008

Journal Articles

The Unmet Need for Extended Thromboprophylaxis in Acutely Ill Medical Patients: The Findings of IMPROVE, ENDORSE and EXCLAIM.

Frederick A Anderson, Jr., PhD, Russell D Hull, MBBS, Sebastian M Schellong, MD, Bruno Deslandes, Victor F Tapson, MD, Meyer Michel Samama, MD, PharmD, Alexander GG Turpie, MD, Roger D Yusen, MD, MPH, Herve Decousus, MD, Alexander T Cohen, MBBS, MSc, MD, FRACP, Manuel Monreal, MD

Blood (2008) 112 (11): 1981.

https://doi.org/10.1182/blood.V112.11.1981.1981

Published: 2008

Journal Articles

Impact of Surgery Type and Co-Morbidities on Venous Thromboembolism prophylaxis Practices in Patients Undergoing Major Surgical Procedures in Acute Care Hospitals Worldwide: A Subanalysis of Data from the ENDORSE Survey

Ajay K Kakkar, PhD, Alexander T Cohen, MBBS, MSc, MD, FRACP, Victor F Tapson, MD, Jean-Francois Bergmann, MD, Samuel Z. Goldhaber, MD, Frederick A Anderson, Jr., PhD

Blood (2008) 112 (11): 171.

https://doi.org/10.1182/blood.V112.11.171.171

Published: 2008

Journal Articles

Venous Thromboembolism Risk and Prophylaxis Practices in Surgical Patients with Active Cancer: Findings from the Global ENDORSE Survey.

Ajay K Kakkar, PhD, Alexander T Cohen, MBBS, MSc, MD, FRACP, Victor F Tapson, MD, Jean-Francois Bergmann, MD, Samuel Z. Goldhaber, MD, Frederick A Anderson, Jr., PhD

Blood (2008) 112 (11): 984.

https://doi.org/10.1182/blood.V112.11.984.984

Published: 2008

Journal Articles

The Effects of the Degree of Mobility Reduction and Prespecified Risk Factors on Venous Thromboembolism Rates in Acutely Ill Medical Patients in the EXCLAIM Study.

Roger D. Yusen, Russell D. Hull, Sebastian M. Schellong, Victor F. Tapson, Manuel Monreal, Meyer-Michel Samama, Alexander G.G. Turpie

Blood (2007) 110 (11): 1862.

https://doi.org/10.1182/blood.V110.11.1862.1862

Published: 2007

Journal Articles

Consistent Venous Thromboembolism Risk Reduction by Extended- Versus Standard-Duration Enoxaparin Prophylaxis in Subgroups of Acutely Ill Medical Patients in the EXCLAIM Study.

Victor F. Tapson, Russell D. Hull, Sebastian M. Schellong, Manuel Monreal, Meyer-Michel Samama, Alexander G.G. Turpie, Roger D. Yusen

Blood (2007) 110 (11): 1863.

https://doi.org/10.1182/blood.V110.11.1863.1863

Published: 2007

Journal Articles

Extended-Duration Enoxaparin for Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: An Evaluation of the EXCLAIM Study Based on a Recently Recommended Composite Efficacy Endpoint.

Sebastian M. Schellong, Russell D. Hull, Victor F. Tapson, Manuel Monreal, Meyer-Michel Samama, Alexander G.G. Turpie, Roger D. Yusen

Blood (2007) 110 (11): 1870.

https://doi.org/10.1182/blood.V110.11.1870.1870

Published: 2007

Journal Articles

Venous Thromboembolic Risk and Suboptimal Prophylaxis in the US Acute Hospital Care Setting: Findings from the ENDORSE Study.

Victor F. Tapson, Alexander T. Cohen, Jean-Francois Bergmann, Samuel Goldhaber, Ajay K. Kakkar, Frederick A. Anderson

Blood (2007) 110 (11): 1858.

https://doi.org/10.1182/blood.V110.11.1858.1858

Published: 2007

Journal Articles

Factors at Admission That Are Predictive of Increased In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE).

Hervé Decousus, MD, Rainer B. Zotz, MD, Victor F. Tapson, MD, Beng H. Chong, MD, PhD, James B. Froehlich, MD, Ricardo Pavanello, MD, Alex C. Spyropoulos, MD, Manuel Monreal, MD, Gordon FitzGerald, Frederick A. Anderson, Jr., PhD, for the IMPROVE Investigators

Blood (2005) 106 (11): 264.

https://doi.org/10.1182/blood.V106.11.264.264

Published: 2005

Journal Articles

Thrombocytopenia Is More Common and Nadir Occurs Earlier with Unfractionated Heparin Than with Low Molecular Weight Heparin - Results from the Prospective Catch Registry.

Stephan Moll, MD, Charles S. Abrams, MD, Lawrence Rice, MD, Richard C. Becker, MD, Peter B. Berger, MD, Kevin J. Anstrom, Emily F. Honeycutt, Eric M. Crespo, MD, Chris Granger, MD, David J. Moliterno, MD, Jo E. Rodgers, pharmD, Steven R. Steinhubl, MD, Victor F. Tapson, MD, Magnus Ohman, MD

Blood (2004) 104 (11): 2197.

https://doi.org/10.1182/blood.V104.11.2197.2197

Published: 2004

Journal Articles

Identification of Medical Patients Who Should Receive Venous Thromboembolism Prophylaxis.

Alexander T. Cohen, Raza Alikhan, Juan I. Arcelus, Jean-François Bergmann, Sylvia Haas, Geno J. Merli, Alex C. Spyropoulos, Victor F. Tapson, Alexander G.G. Turpie

Blood (2004) 104 (11): 1786.

https://doi.org/10.1182/blood.V104.11.1786.1786

Published: 2004

Journal Articles

Red Blood Cell S -Nitrosohemoglobin Deficiency in Pulmonary Arterial Hypertension.

John R. Pawloski, M.D., Ph.D., Timothy J. McMahon, M.D., Ph.D., Martin P. Moya, M.D., Andrew J. Gow, Ph.D., Yuh-Chin T. Huang, M.D., Benjamin J. Luchsinger, M.D., Abigail D. Krichman, Thomas M. Bashore, M.D., Robert M. Califf, M.D., David J. Singel, Ph.D., Claude A. Piantadosi, M.D., Victor F. Tapson, M.D., Jonathan S. Stamler, M.D.

Blood (2004) 104 (11): 1583.

https://doi.org/10.1182/blood.V104.11.1583.1583

Published: 2004

Journal Articles

The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE): Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients.

Victor F. Tapson, Herve Decousus, Jean-Fran[ccedi]ois Bergmann, Beng H. Chong, James B. Froehlich, Ajay K. Kakkar, Geno J. Merli, Manuel Monreal, Mashio Nakamura, Riccardo Pavanello, Mario Pini, Franco Piovella, Alex C. Spyropoulos, Alexander G.G. Turpie, Rainer B. Zotz, Gordon FitzGerald, Frederick A. Anderson, Jr, for the IMPROVE investigators

Blood (2004) 104 (11): 1762.

https://doi.org/10.1182/blood.V104.11.1762.1762

Published: 2004

Journal Articles

Incidence and Risk Factors for In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from IMPROVE.

Hervé Decousus, Rainer Zotz, Victor F. Tapson, Beng Chong, Manuel Monreal, Gordon FitzGerald, Frederick A. Anderson, Jr, for the IMPROVE Investigators

Blood (2004) 104 (11): 1763.

https://doi.org/10.1182/blood.V104.11.1763.1763

Published: 2004

Journal Articles

Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients with Either Previous Cancer or Currently Active Cancer: Findings from IMPROVE.

Beng H. Chong, Ajay K. Kakkar, Victor F. Tapson, Gordon Fitzgerald, Frederick A. Anderson, Jr, for the IMPROVE Investigators

Blood (2004) 104 (11): 1767.

https://doi.org/10.1182/blood.V104.11.1767.1767

Published: 2004

NARROW

The MAGELLAN Study: An Analysis of Outcomes Utilizing D-Dimer

Venous Thromboembolism Risk in Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Sub-Analysis of the EXCLAIM Study

The Impact of Age on the Efficacy and Safety of Extended-Duration Thromboprophylaxis in Acutely Ill Medical Patients with Recent Immobility: A Sub-Group Analysis from the EXCLAIM Study

The Unmet Need for Extended Thromboprophylaxis in Acutely Ill Medical Patients: The Findings of IMPROVE, ENDORSE and EXCLAIM.

Impact of Surgery Type and Co-Morbidities on Venous Thromboembolism prophylaxis Practices in Patients Undergoing Major Surgical Procedures in Acute Care Hospitals Worldwide: A Subanalysis of Data from the ENDORSE Survey

Venous Thromboembolism Risk and Prophylaxis Practices in Surgical Patients with Active Cancer: Findings from the Global ENDORSE Survey.

The Effects of the Degree of Mobility Reduction and Prespecified Risk Factors on Venous Thromboembolism Rates in Acutely Ill Medical Patients in the EXCLAIM Study.

Consistent Venous Thromboembolism Risk Reduction by Extended- Versus Standard-Duration Enoxaparin Prophylaxis in Subgroups of Acutely Ill Medical Patients in the EXCLAIM Study.

Extended-Duration Enoxaparin for Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: An Evaluation of the EXCLAIM Study Based on a Recently Recommended Composite Efficacy Endpoint.

Venous Thromboembolic Risk and Suboptimal Prophylaxis in the US Acute Hospital Care Setting: Findings from the ENDORSE Study.

Factors at Admission That Are Predictive of Increased In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE).

Thrombocytopenia Is More Common and Nadir Occurs Earlier with Unfractionated Heparin Than with Low Molecular Weight Heparin - Results from the Prospective Catch Registry.

Identification of Medical Patients Who Should Receive Venous Thromboembolism Prophylaxis.

Red Blood Cell S -Nitrosohemoglobin Deficiency in Pulmonary Arterial Hypertension.

The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE): Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients.

Incidence and Risk Factors for In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from IMPROVE.

Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients with Either Previous Cancer or Currently Active Cancer: Findings from IMPROVE.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only